Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;33(9):1193-1205.
doi: 10.1007/s10552-022-01605-7. Epub 2022 Jul 13.

Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods study

Bernard Tawfik  1   2   3 , Ellen Burgess  4 , Mikaela Kosich  4 , Shoshana Adler Jaffe  4 , Dolores D Guest  4   5 , Ursa Brown-Glaberman  4   6 , V Shane Pankratz  4   5 , Andrew Sussman  4   7
Affiliations

Patient, provider, and nurse preferences of patient reported outcomes (PRO) and side effect management during cancer treatment of underrepresented racial and ethnic minority groups, rural and economically disadvantaged patients: a mixed methods study

Bernard Tawfik et al. Cancer Causes Control. 2022 Sep.

Abstract

Purpose: The purpose of this study was to evaluate patient, oncologist and nurse perspectives on side effects and patient reported outcomes (PROs) with the question of how to optimize side effect management and PRO tools in this unique population.

Methods: This pilot study utilized a mixed method explanatory design. Patients receiving intravenous (IV) chemotherapy from June to August 2020 were surveyed about side effect burden and PRO system preferences. Providers and nurses (PN) completed complementary surveys. Semi-structured phone interviews were conducted among a subset of each group.

Results: Of 90 patient surveys collected; 51.1% minority, 35.6% rural, and 40.0% income < $30,000, 48% felt side effect management was a significant issue. All patients reported access to a communication device but 12.2% did not own a cell phone; 68% smart phone, 20% cell phone, 22% landline, 53% computer, and 39% tablet. Patients preferred a response to reported side effects within 0-3 h (73%) while only 29% of the 55 PN surveyed did (p < 0.0001). Interviews reinforced that side effect burden was a significant issue, the varied communication devices, and a PRO system could improve side effect management.

Conclusion: In a non-White, rural and low-income patient population, 87.8% of patients reported owning a cell phone. Although all agreed side effect management was a prominent issue, expectations between patients and PN differed substantially. Qualitative data echoed the above and providing concrete suggestions to inform development of a PRO program and side effect mitigation strategies among a diverse patient population.

Keywords: Minority; Mixed methods; Oncology; Patient reported outcomes; Quality of life; Rural; Side effects.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors have no relevant financial or non-financial interests to disclose.

Figures

Fig. 1
Fig. 1
Device access and preferences for providers and patients
Fig. 2
Fig. 2
Desired response time to side effect concerns
See this image and copyright information in PMC

References

    1. Shapiro CL, Recht A (2001) Side effects of adjuvant treatment of breast cancer. N Engl J Med 344(26):1997–2008. 10.1056/NEJM200106283442607 - DOI - PubMed
    1. Lin JJ, Chao J, Bickell NA, Wisnivesky JP (2017) Patient-provider communication and hormonal therapy side effects in breast cancer survivors. Women Health 57(8):976–989. 10.1080/03630242.2016.1235071 - DOI - PMC - PubMed
    1. Gandhi S et al. (2015) Oral anticancer medication adherence, toxicity reporting, and counseling: a study comparing health care providers and patients. J Oncol Pract 11(6):498–504. 10.1200/JOP.2015.004572 - DOI - PubMed
    1. Nabulsi NA et al. (2020) Self-reported health and survival in older patients diagnosed with multiple myeloma. Cancer Causes Control 31(7):641–650. 10.1007/s10552-020-01305-0 - DOI - PMC - PubMed
    1. Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK (2002) Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 288(23):3027–3034. 10.1001/jama.288.23.3027 - DOI - PubMed